Misbah Tahir
CFO & Principal Accounting OfficerMr. Misbah Tahir, CPA, is Chief Financial Officer of Maze Therapeutics, Inc. from September 2, 2025 and serves as its Principal Accounting Officer from June 1, 2026. He had been Vice President of Finance at Dermira, Inc. from January 2014 to December 2018. Mr. Tahir joined Dermira in 2014. He served as Chief Financial Officer at IGM Biosciences Inc. since January 2019 until August 1, 2025. He has finance and business planning experience, including over 12 years in the biotechnology industry. Prior to joining Dermira, he held finance leadership positions of increasing responsibility at Onyx Pharmaceuticals, Human Genome Sciences, Inc. and Amgen. He began his career as a management consultant at Oliver Wyman, where he developed growth strategies for high-tech, energy and manufacturing clients. He is a certified public accountant (inactive). Mr. Tahir earned a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from the University of Michigan Business School.
Positions
- Company NameMaze Therapeutics, Inc.Stock CodeMAZEPositionCFO & Principal Accounting OfficerColleagues
- JVJason V. ColomaCEO & Director
- HHHerve HoppenotChairman of the Board
- HSHarold S. BernsteinPresident of Research & Development and Chief Medical Officer
- VVVipin VijayakumarSenior Vice President of Technology and Business Operations
- MHMaarten HoekChief Scientific Officer
- DKDaniel K. SpiegelmanIndependent Non-Employee Director
- JEJonathan E. LimIndependent Non-Employee Director
- CJCharles J. HomcyDirector
